Interleukin 10-2849AA genotype protects against pre-eclampsia

被引:38
作者
de Groot, CJM
Jansen, MWJC
Bertina, RM
Schonkeren, JJM
Helmerhorst, F
Huizinga, TWJ
机构
[1] Erasmus Med Ctr, Dept Obstet & Gynecol, NL-3015 GJ Rotterdam, Netherlands
[2] Leiden Univ, Ctr Med, Dept Hematol, Leiden, Netherlands
[3] Leiden Univ, Ctr Med, Dept Rheumatol, Leiden, Netherlands
[4] Leiden Univ, Ctr Med, Dept Obstet Gynecol & Reprod Med, Leiden, Netherlands
关键词
interleukin; 10; pre-eclampsia; pathofysiology; pregnancy;
D O I
10.1038/sj.gene.6364092
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Recently, it has been described that human fertility is associated with the interleukin 10 (IL10) -2849 AA genotype. Preeclampsia is the most common pregnancy-specific complication. In the pathogenesis of pre-eclampsia, IL10 may affect maternal intra vascular inflammation as well as endothelial dysfunction. Therefore, we tested the hypothesis that pre-eclampsia is associated with genetic variation in the IL10 promoter region in a case-control study for pre-eclampsia. Women homozygous for the IL10-2849A allele have a threefold reduced risk for pre-eclampsia compared to controls (odds ratio 0.29; 95% CI 0.10-0.83). No differences in genotype frequency were found for polymorphisms in the IL10 promoter region at positions -1082, -819 and -592. This suggests that there is a genetically determined mechanism which protects the mother against pre-eclampsia, as reflected in the lower frequency of the IL10-2849AA genotype in pre-eclamptic women.
引用
收藏
页码:313 / 314
页数:2
相关论文
共 14 条
[1]   Preeclampsia and genetic risk factors for thrombosis: A case-control study [J].
De Groot, CJM ;
Bloemenkamp, KWM ;
Duvekot, EJ ;
Helmerhorst, FM ;
Bertina, RM ;
Van der Meer, F ;
De Ronde, H ;
Oei, SG ;
Kanhai, HHH ;
Rosendaal, FR .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 181 (04) :975-980
[2]   Frequency of functional interleukin-10 promoter polymorphism is different between relapse-onset and primary progressive multiple sclerosis [J].
de Jong, BA ;
Westendorp, RGJ ;
Eskdale, J ;
Uitdehaag, BMJ ;
Huizinga, TWJ .
HUMAN IMMUNOLOGY, 2002, 63 (04) :281-285
[3]   Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia [J].
Djurovic, S ;
Clausen, T ;
Wergeland, R ;
Brosstad, F ;
Berg, K ;
Henriksen, T .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2002, 109 (07) :759-764
[4]   Why isn't the fetus rejected? [J].
Erlebacher, A .
CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (05) :590-593
[5]   Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus [J].
Gibson, AW ;
Edberg, JC ;
Wu, JM ;
Westendorp, RGJ ;
Huizinga, TWJ ;
Kimberly, RP .
JOURNAL OF IMMUNOLOGY, 2001, 166 (06) :3915-3922
[6]  
Hennessy A, 1999, J IMMUNOL, V163, P3491
[7]  
JONG BA, 2002, HUM IMMUNOL, V63, P281
[8]   Inconsistent detection of interleukin-10 in the maternal serum [J].
Marjono, B ;
Tong, S ;
Wallace, E .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2002, 109 (12) :1426-1427
[9]   Pathogenesis and genetics of pre-eclampsia [J].
Roberts, JM ;
Cooper, DW .
LANCET, 2001, 357 (9249) :53-56
[10]   IL-10 is an autocrine inhibitor of human placental cytotrophoblast MMP-9 production and invasion [J].
Roth, I ;
Fisher, SJ .
DEVELOPMENTAL BIOLOGY, 1999, 205 (01) :194-204